Cargando…

Immune checkpoint inhibitors and potential risk of thromboembolic events: Analysis of the WHO global database of individual case safety reports

INTRODUCTION: Thromboembolic events with the use of immune checkpoint inhibitors (ICIs) in patients with cancer have been reported in few studies. However, the detailed profile of these cases remains mostly uncertain. METHOD: A descriptive analysis of Thromboembolic events associated with ICIs retri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alghamdi, Eman A., Aljohani, Hadir, Alghamdi, Waad, Alharbi, Fawaz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508630/ https://www.ncbi.nlm.nih.gov/pubmed/36164566 http://dx.doi.org/10.1016/j.jsps.2022.06.010

Ejemplares similares

Risk of Lichen Sclerosus and Lichen Planus in Patients Receiving Immune Checkpoint Inhibitors
por: Alharbi, Ahmad, et al.
Publicado: (2022)

Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reports
por: Noseda, Roberta, et al.
Publicado: (2019)

Thromboembolic Events Related to Treatment with Checkpoint Inhibitors: Report of Two Cases
por: Tsukamoto, Jessica, et al.
Publicado: (2018)

Immune Checkpoint Inhibitor-Related Cytokine Release Syndrome: Analysis of WHO Global Pharmacovigilance Database
por: Ceschi, Alessandro, et al.
Publicado: (2020)

The Association Between Oral Helicobacter pylori and Gastric Complications: A Comprehensive Review
por: Alkhaldi, Njoud K, et al.
Publicado: (2022)

Immune Checkpoint Inhibitor-Induced Endocrine Adverse Events in Cancer Patients at a Tertiary Care Center in Saudi Arabia
por: Alqahtani, Ali, et al.
Publicado: (2023)

Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports
por: Wakao, Rika, et al.
Publicado: (2019)

Reporting of Thromboembolic Events with JAK Inhibitors: Analysis of the FAERS Database 2010–2019
por: Setyawan, Juliana, et al.
Publicado: (2021)

SAT453 Endocrine Related Adverse Events Of Immune Checkpoint Inhibitors In Cancer Patients Visiting Tertiary Care Center In Saudi Arabia
por: Mohammed Alqahtani, Ali, et al.
Publicado: (2023)

Impact of Asthma Education Program 2020-2021 on Asthma Control Among Bronchial Asthma Children in Madinah City, Saudi Arabia
por: Alhazmi, Jawharah, et al.
Publicado: (2023)

Association of immune checkpoint inhibitors therapy with arterial thromboembolic events in cancer patients: A retrospective cohort study
por: Zhu, Jie, et al.
Publicado: (2023)

Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma
por: Scheiner, Bernhard, et al.
Publicado: (2022)

Renal Safety Profile of EGFR Targeted Therapies: A Study from VigiBase(®) the WHO Global Database of Individual Case Safety Reports
por: Crosnier, Alexandre, et al.
Publicado: (2021)

Radiological Determinants of Thromboembolic Events in COVID-19 Pneumonia: A Retrospective Study
por: Ghadeeb, Mohd, et al.
Publicado: (2022)

The Potential Association Between Periodontal Diseases and Adverse Pregnancy Outcomes in Pregnant Women: A Systematic Review of Randomized Clinical Trials
por: Alnasser, Bashayer H, et al.
Publicado: (2023)

Analysis of immune‐related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database
por: Hasegawa, Shiori, et al.
Publicado: (2020)

Statin-Associated Polymyalgia Rheumatica. An Analysis Using WHO Global Individual Case Safety Database: A Case/Non-Case Approach
por: de Jong, Hilda J. I., et al.
Publicado: (2012)

Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients
por: Nichetti, Federico, et al.
Publicado: (2019)

Ocular adverse events with immune checkpoint inhibitors
por: Fang, Tony, et al.
Publicado: (2019)

Mucocutaneous adverse events to immune checkpoint inhibitors
por: Muhaj, Fiorinda, et al.
Publicado: (2023)

Unexpected Adverse Events of Immune Checkpoint Inhibitors
por: Shalata, Walid, et al.
Publicado: (2023)

Risk Factors, Incidence, and Prognosis of Thromboembolism in Cancer Patients Treated With Immune Checkpoint Inhibitors
por: Zou, Xue-lin, et al.
Publicado: (2021)

Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database
por: Hoisnard, Léa, et al.
Publicado: (2022)

Pituitary-Related Adverse Events and Onset Patterns Caused by Immune Checkpoint Inhibitors: Analysis Using the Japanese Adverse Drug Event Report Database
por: Asano, Hiroki, et al.
Publicado: (2023)

The Safety Profiles of Two First-Generation NTRK Inhibitors: Analysis of Individual Case Safety Reports from the FDA Adverse Event Reporting System (FAERS) Database
por: Liguori, Valerio, et al.
Publicado: (2023)

Hepatic failure associated with immune checkpoint inhibitors: An analysis of the Food and Drug Administration Adverse Event Reporting System database
por: Xu, Ye, et al.
Publicado: (2023)

The prevalence and pattern of complementary and alternative medicine use among cancer patients in a tertiary oncology center: a cross-sectional study
por: Almouaalamy, Nabil Abdullah, et al.
Publicado: (2023)

Safety of checkpoint inhibitors for cancer treatment: strategies for patient monitoring and management of immune-mediated adverse events
por: Davies, Marianne, et al.
Publicado: (2017)

Imaging of Adverse Events Related to Checkpoint Inhibitor Therapy
por: Vani, Vanina, et al.
Publicado: (2020)

Cardiac Adverse Events Related to Immune Checkpoint Inhibitors
por: Gujral, Dorothy M., et al.
Publicado: (2020)

Cardiovascular events after the initiation of immune checkpoint inhibitors
por: Suzuki, Yuta, et al.
Publicado: (2023)

Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival
por: Sussman, Tamara A, et al.
Publicado: (2021)

COVID-19 Vaccine-Associated Transient Global Amnesia: A Disproportionality Analysis of the WHO Safety Database
por: Merino, Diane, et al.
Publicado: (2022)

Mania as a Rare Adverse Event Secondary to Steroid Eye Drops
por: Alsalem, Moayyad, et al.
Publicado: (2022)

A Measles Outbreak in Riyadh in 2023: Clinical and Epidemiological Characteristics
por: Alruqaie, Nourah, et al.
Publicado: (2023)

Pericardial Toxicities Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS) Database
por: Ma, Zhuo, et al.
Publicado: (2021)

Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
por: Zhou, Chaozheng, et al.
Publicado: (2023)

Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database
por: Hasegawa, Shiori, et al.
Publicado: (2017)

Thromboembolic Events Burden in Patients With Solid Tumors and Their Predisposing Factors
por: Bazarbashi, Shouki, et al.
Publicado: (2022)

Gastrointestinal toxicities associated with immune checkpoint inhibitors: a disproportionality analysis leveraging VigiBase, the WHO Adverse Drug Reaction Database
por: HUANG, Sifu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_er3d5j722rrs52jdp68vjj36kg